Why Choose Us
Our Strength
23 century and Beike had a distinguished scientist team and a powerful scientific research network alliance that constructed over 400 team members working on different disciplines such as clinical medicine, molecular biology, biochemistry, cytobiology, genetics, clinical laboratory science, and hematology.
Beike Biotechnology has over a decade of experience and expertise in immune cell and stem cell research, development, treatment and even running a stem cell hospitals. With their strong scientific research cooperation alliance with renowned universities and research institutes worldwide, such as VA Hospital of Stanford University, Huazhong University of Science and Technology, Sun Yat-sen University, Chinese University of Hong Kong, Shenzhen High School, Tsinghua University, Zhengzhou University, Institute of Blood Transfusion, Academy of Military Medical Sciences, Beijing Wuzuze Technology Development Foundation, Navy general hospital of PLA, Xijing Hospital and The Fourth Military Medical University allows them to continue advancing in the area of immune cell and stem cell treatment.
Our Vision
23 Century Life Science desires to establish the largest advance cell centre in South East Asia equip with latest technology and expertise from Beike Biotechnology and a state-of-the-art cGMP laboratory fulfilling the requirement of CGTP (cell & gene therapy products), ASEAN Common Technical Dossier (ACTD) and Pharmaceutical Inspection Co-operation Scheme (PICS). Our aim is to promote health by providing hope to patients who suffer from diseases which are incurable from modern medicines using cells as a treatment option.
-
- 67 International & National Patents
- Advisory Board for Cell Preparation Standards/Guideline
- Cell seed purification technology (International Patent)
- 4th generation Cell Manufacturing > 80% cell viability
-
- Manufacturing process that passed the audit of the National Drug Regulatory
- Highest clean room standard (Grade B,A)
- Third party testing (Clinical Grade approved by NPRA)
- More than 45 types of main raw materials approved for clinical grade
- Every cell must be traceable with 24 hours surveillance
- Stringent test before the final product will be release out from laboratory
-
- Beike has carried out more than 20,000 cellular clinical studies and application in more than 70 countries globally
- We are one of the largest and most comprehensive stem cell research institution in the world today